SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today the launch of its first crowdfunding campaign with Indiegogo seeking to raise $100,000 dollars to complete preclinical testing for VallovaxTM, an immunotherapeutic product which selectively kills blood vessels feeding the tumor.